SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $766,539,858 |
| Positions | 105 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD | TEVA | SPONSORED ADS | $50,822,778 | 1,500,082 |
| MINERALYS THERAPEUTICS INC | MLYS | COM | $39,659,818 | 1,469,971 |
| TOWER SEMICONDUCTOR LTD | TSEM | SHS NEW | $28,218,190 | 108,265 |
| SPDR SERIES TRUST | XBI | ST STR SP BIOT | $23,737,500 | 150,000 |
| SYNDAX PHARMACEUTICALS INC | SNDX | COM | $22,179,287 | 1,014,606 |
| BIOGEN INC | BIIB | COM | $21,606,000 | 100,000 |
| BIOGEN INC | BIIB | COM | $20,877,014 | 96,626 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | COM | $19,649,815 | 588,494 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | COM | $18,799,631 | 328,550 |
| CYTOKINETICS INC | CYTK | COM NEW | $18,740,693 | 219,987 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.